Showing 9,741 - 9,760 results of 68,530 for search '(( 5 a decrease ) OR ( 50 ((((mean decrease) OR (we decrease))) OR (nn decrease)) ))', query time: 1.02s Refine Results
  1. 9741
  2. 9742

    Table 1_Multi-omics-based phenotyping of AFG3L2-mutant lymphoblasts determines key factors of a pathophysiological interplay between mitochondrial vulnerability and neurodegenerati... by Menekse Oeztuerk (20756606)

    Published 2025
    “…Mutations in AFG3L2 are implicated in a spectrum of diseases, including spinocerebellar ataxia type 28 (SCA28) and spastic ataxia 5 (SPAX5), as well as other systemic conditions. …”
  3. 9743

    Image 1_Multi-omics-based phenotyping of AFG3L2-mutant lymphoblasts determines key factors of a pathophysiological interplay between mitochondrial vulnerability and neurodegenerati... by Menekse Oeztuerk (20756606)

    Published 2025
    “…Mutations in AFG3L2 are implicated in a spectrum of diseases, including spinocerebellar ataxia type 28 (SCA28) and spastic ataxia 5 (SPAX5), as well as other systemic conditions. …”
  4. 9744
  5. 9745

    Data_Sheet_1_Mapping of a Regulatory Site of the Escherichia coli ADP-Glucose Pyrophosphorylase.PDF by Jaina A. Bhayani (7426799)

    Published 2019
    “…Other potent activator analogs include 1,6-hexanediol bisphosphate (HBP) and pyridoxal 5′-phosphate (PLP). Recently, a crystal structure with FBP bound was reported (PDB ID: 5L6S). …”
  6. 9746

    Image3_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…We compared these 4 compounds to a DNA-PK inhibitor (AZD7648) in three patient-derived B-ALL cell lines (LAX56, BLQ5 and LAX7R) and in two mature B-cell lines (3301015 and 5680001) as controls. …”
  7. 9747

    Image1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpg by Heather A. Ogana (11774297)

    Published 2023
    “…We compared these 4 compounds to a DNA-PK inhibitor (AZD7648) in three patient-derived B-ALL cell lines (LAX56, BLQ5 and LAX7R) and in two mature B-cell lines (3301015 and 5680001) as controls. …”
  8. 9748

    Image2_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…We compared these 4 compounds to a DNA-PK inhibitor (AZD7648) in three patient-derived B-ALL cell lines (LAX56, BLQ5 and LAX7R) and in two mature B-cell lines (3301015 and 5680001) as controls. …”
  9. 9749

    Bacterial strains and plasmids. by Eunsil Choi (8271039)

    Published 2025
    “…Typhimurium strains revealed a defect in ribosome assembly at 20°C, with the accumulation of abnormal 50S ribosomal subunits. We further demonstrated that the absence of BipA in <i>S</i>. …”
  10. 9750

    Using a Bayesian network to understand the importance of coastal storms and undeveloped landscapes for the creation and maintenance of early successional habitat by Sara L. Zeigler (497021)

    Published 2019
    “…We found that Hurricane Sandy increased piping plover habitat by 9 to 300% at 4 of 5 study sites but that one site saw a decrease in habitat by 27%. …”
  11. 9751

    Epidemic risk for the effective reproduction numbers (<i>R</i><sub><i>e</i></sub>) corresponding to reduced risk (1.1) and the minimum (1.4), median (2.8), and maximum (4.4) estima... by Emily M. Javan (15194865)

    Published 2023
    “…Epidemic risk is the percent of 100,000 simulations, for each <i>R</i><sub><i>e</i></sub>, that become epidemics. We classified a simulation as an epidemic if it reached 2,000 cumulative infections and had a minimum prevalence of 50 new infections per day. …”
  12. 9752

    Original data. by Yaotian Fan (5917766)

    Published 2025
    “…Person-Vocation Fit (P-V Fit) may play a key role in preventing burnout. …”
  13. 9753
  14. 9754
  15. 9755
  16. 9756
  17. 9757

    Data obtained from monitoring patients. by Ana Gabriela Gomes Ferrari Strang (17068913)

    Published 2023
    “…Three decreasing values of immunoglobulin G were a security parameter for stopping the child’s medication in the exposed group (50/61). …”
  18. 9758

    General characteristics and statistical analysis. by Ana Gabriela Gomes Ferrari Strang (17068913)

    Published 2023
    “…Three decreasing values of immunoglobulin G were a security parameter for stopping the child’s medication in the exposed group (50/61). …”
  19. 9759

    Structure–Activity Relationships and Discovery of (<i>S</i>)‑5‑(<i>tert</i>-Butyl)-11-(difluoromethoxy)-9-methoxy-2-oxo-1,2,5,6-tetrahydropyrido[2′,1′:2,3]imidazo[4,5‑<i>h</i>]quin... by Dimitar Gotchev (1893928)

    Published 2024
    “…Optimization of a novel series of PAPD5/7 inhibitors that decrease HBsAg levels led to the tetracyclic 2-pyridone <b>AB-161</b>, which was similarly potent to <b>AB-452</b> <i>in vitro</i> and <i>in vivo</i> but showed dramatically higher rodent liver-to-plasma ratios. …”
  20. 9760